Global and China Deoxyribonucleic Acid Vaccines Industry

Global and China Deoxyribonucleic Acid (DNA) Vaccines Industry Ecological Development and Analysis Report 2023

Global and China Deoxyribonucleic Acid Vaccines Industry

Global and China Deoxyribonucleic Acid (DNA) Vaccines Industry Ecological Development and Analysis Report 2023


The Global Deoxyribonucleic Acid (DNA) Vaccines Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like {playerNamesStr}

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

In terms of market side, this report researches the Deoxyribonucleic Acid (DNA) Vaccines revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.

The global Deoxyribonucleic Acid (DNA) Vaccines market size in 2022 is 465.6 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 7.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Deoxyribonucleic Acid (DNA) Vaccines market include F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), and Pfizer Inc. (U.S.). The share of the top 3 players in the Deoxyribonucleic Acid (DNA) Vaccines market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Deoxyribonucleic Acid (DNA) Vaccines market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Human DNA Vaccines accounted for XX% of Deoxyribonucleic Acid (DNA) Vaccines market in 2022. Animal DNA Vaccines share of XX%.

Human Diseases accounted for XX% of the Deoxyribonucleic Acid (DNA) Vaccines market in 2022. Veterinary Disease accounts for XX%.

Report Includes:

This report presents an overview of global market for Deoxyribonucleic Acid (DNA) Vaccines. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key players of Deoxyribonucleic Acid (DNA) Vaccines, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Deoxyribonucleic Acid (DNA) Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Deoxyribonucleic Acid (DNA) Vaccines market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Deoxyribonucleic Acid (DNA) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Deoxyribonucleic Acid (DNA) Vaccines sales, projected growth trends, technology, application and end-user industry.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Market Data Breakdown by Regions

North America

United States

Canada

China

Asia Pacific (Excluding China)

Japan

Korea

Southeast Asia

India

Australia

EMEA

Europe

Germany

France

UK

Italy

Russia

Nordic

Middle East

Africa

Latin America

Brazil

Argentina

Mexico

Some prominent players in the market includes:

F. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd. (Israel)

Sanofi (France)

Pfizer Inc. (U.S.)

GSK plc (U.K.)

Novartis AG (Switzerland)

Serum Institute of India Pvt. Ltd (India),

Fotona (U.S.)

G.C. Biopharma (South Korea)

Sanofi (France), Zoetis (U.S.).

INOVIO Pharmaceuticals (U.S.).

General Electric (U.S.)

Biomay AG (Austria)

Valneva SE (France)

Market Data Breakdown by Type

Human DNA Vaccines

Animal DNA Vaccines

Market Data Breakdown by Applications

Human Diseases

Veterinary Disease

Allergies

Others

Table of Content

1 Deoxyribonucleic Acid (DNA) Vaccines Market Introduction and Overview

1.1 Deoxyribonucleic Acid (DNA) Vaccines Definition

1.2 Research Purposes

1.3 Currency Rate

1.4 Report Timeline

1.5 Economic Analysis of Global Regions

1.6 Inflation Analysis

1.7 The Impact of the Russian-Ukrainian War on the Market

2 Market Competition by Manufacturers

2.1 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue and Market Share by Manufacturer

2.2 Manufacturers Deoxyribonucleic Acid (DNA) Vaccines Production Sites, Area Served, Product Types

2.3 Deoxyribonucleic Acid (DNA) Vaccines Market Competitive Situation and Trends

2.3.1 Deoxyribonucleic Acid (DNA) Vaccines Market Concentration Rate

2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023

2.3.3 Mergers & Acquisitions, Expansion

3 Global Deoxyribonucleic Acid (DNA) Vaccines Historical Market Analysis by Type

3.1 Market Size Analysis by Types

3.1.4 Global Deoxyribonucleic Acid (DNA) Vaccines Market Share by Type 2018 VS 2022

3.2 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue and Market Share by Type

4 Global Deoxyribonucleic Acid (DNA) Vaccines Historical and Forecast Market Analysis by Application

4.1 Market Size Analysis by Application

4.1.4 Global Deoxyribonucleic Acid (DNA) Vaccines Market Share by Application 2018 VS 2022

4.2 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Share by Application (2018-2023)

5 Global Market Growth Trends Analysis

5.1 Global Deoxyribonucleic Acid (DNA) Vaccines Market Size (2018-2023)

5.2 Deoxyribonucleic Acid (DNA) Vaccines Growth Trends Analysis by Regions

5.2.1 Deoxyribonucleic Acid (DNA) Vaccines Market Size by Regions: 2018 VS 2023 VS 2029

5.2.2 Deoxyribonucleic Acid (DNA) Vaccines Historic Revenue Market Size by Regions (2018-2023)

5.3 North America

5.3.1 North America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Countries (2018-2023)

5.3.2 North America SWOT Analysis

5.3.3 United States

5.3.4 Canada

5.4 China

5.4.1 China SWOT Analysis

5.5 Asia Pacific (Excluding China)

5.5.1 Asia Pacific Deoxyribonucleic Acid (DNA) Vaccines Revenue by Countries (2018-2023)

5.5.2 Asia Pacific SWOT Analysis

5.5.3 Japan

5.5.4 Korea

5.5.5 Southeast Asia

5.5.6 India

5.5.7 Australia

5.6 EMEA

5.6.1 EMEA Deoxyribonucleic Acid (DNA) Vaccines Revenue by Countries (2018-2023)

5.6.2 EMEA SWOT Analysis

5.6.3 Europe

5.6.4 Middle East

5.6.5 Africa

5.7 Latin America

5.7.1 Latin America Deoxyribonucleic Acid (DNA) Vaccines Revenue by Countries (2018-2023)

5.7.2 Latin America SWOT Analysis

5.7.3 Brazil

5.7.4 Argentina

5.7.5 Mexico

6 Players Profiles

6.1 F. Hoffmann-La Roche Ltd. (Switzerland)

6.1.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile

6.1.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.1.3 F. Hoffmann-La Roche Ltd. (Switzerland) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.1.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

6.1.5 SWOT Analysis

6.2 Mylan N.V. (U.S.)

6.2.1 Mylan N.V. (U.S.) Company Profile

6.2.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.2.3 Mylan N.V. (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.2.4 Mylan N.V. (U.S.) Business Overview

6.2.5 SWOT Analysis

6.3 Teva Pharmaceutical Industries Ltd. (Israel)

6.3.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Profile

6.3.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.3.3 Teva Pharmaceutical Industries Ltd. (Israel) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.3.4 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview

6.3.5 SWOT Analysis

6.4 Sanofi (France)

6.4.1 Sanofi (France) Company Profile

6.4.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.4.3 Sanofi (France) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.4.4 Sanofi (France) Business Overview

6.4.5 SWOT Analysis

6.5 Pfizer Inc. (U.S.)

6.5.1 Pfizer Inc. (U.S.) Company Profile

6.5.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.5.3 Pfizer Inc. (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.5.4 Pfizer Inc. (U.S.) Business Overview

6.5.5 SWOT Analysis

6.6 GSK plc (U.K.)

6.6.1 GSK plc (U.K.) Company Profile

6.6.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.6.3 GSK plc (U.K.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.6.4 GSK plc (U.K.) Business Overview

6.6.5 SWOT Analysis

6.7 Novartis AG (Switzerland)

6.7.1 Novartis AG (Switzerland) Company Profile

6.7.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.7.3 Novartis AG (Switzerland) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.7.4 Novartis AG (Switzerland) Business Overview

6.7.5 SWOT Analysis

6.8 Serum Institute of India Pvt. Ltd (India),

6.8.1 Serum Institute of India Pvt. Ltd (India), Company Profile

6.8.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.8.3 Serum Institute of India Pvt. Ltd (India), Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.8.4 Serum Institute of India Pvt. Ltd (India), Business Overview

6.8.5 SWOT Analysis

6.9 Fotona (U.S.)

6.9.1 Fotona (U.S.) Company Profile

6.9.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.9.3 Fotona (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.9.4 Fotona (U.S.) Business Overview

6.9.5 SWOT Analysis

6.10 G.C. Biopharma (South Korea)

6.10.1 G.C. Biopharma (South Korea) Company Profile

6.10.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.10.3 G.C. Biopharma (South Korea) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.10.4 G.C. Biopharma (South Korea) Business Overview

6.10.5 SWOT Analysis

6.11 Sanofi (France), Zoetis (U.S.).

6.11.1 Sanofi (France), Zoetis (U.S.). Company Profile

6.11.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.11.3 Sanofi (France), Zoetis (U.S.). Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.11.4 Sanofi (France), Zoetis (U.S.). Business Overview

6.11.5 SWOT Analysis

6.12 INOVIO Pharmaceuticals (U.S.).

6.12.1 INOVIO Pharmaceuticals (U.S.). Company Profile

6.12.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.12.3 INOVIO Pharmaceuticals (U.S.). Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.12.4 INOVIO Pharmaceuticals (U.S.). Business Overview

6.12.5 SWOT Analysis

6.13 General Electric (U.S.)

6.13.1 General Electric (U.S.) Company Profile

6.13.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.13.3 General Electric (U.S.) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.13.4 General Electric (U.S.) Business Overview

6.13.5 SWOT Analysis

6.14 Biomay AG (Austria)

6.14.1 Biomay AG (Austria) Company Profile

6.14.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.14.3 Biomay AG (Austria) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.14.4 Biomay AG (Austria) Business Overview

6.14.5 SWOT Analysis

6.15 Valneva SE (France)

6.15.1 Valneva SE (France) Company Profile

6.15.2 Deoxyribonucleic Acid (DNA) Vaccines Product Overview

6.15.3 Valneva SE (France) Deoxyribonucleic Acid (DNA) Vaccines Market Performance (2018-2023)

6.15.4 Valneva SE (France) Business Overview

6.15.5 SWOT Analysis

7 Deoxyribonucleic Acid (DNA) Vaccines Business Cost Analysis

7.1 Labor Cost Analysis

7.2 Proportion of Manufacturing Cost Structure

7.3 Deoxyribonucleic Acid (DNA) Vaccines Industrial Chain Analysis

8 Deoxyribonucleic Acid (DNA) Vaccines Industry Dynamic Analysis

8.1 Deoxyribonucleic Acid (DNA) Vaccines Market Trends Analysis

8.2 Deoxyribonucleic Acid (DNA) Vaccines Market Drivers Analysis

8.3 Deoxyribonucleic Acid (DNA) Vaccines Market Challenges Analysis

8.4 Deoxyribonucleic Acid (DNA) Vaccines Market Restraints Analysis

9 Global Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis by Type & Application

9.1 Global Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Forecast by Type (2023-2029)

9.2 Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Forecast by Application (2023-2029)

10 Global Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis by Region

10.1 Deoxyribonucleic Acid (DNA) Vaccines Revenue Market Forecast by Region (2023-2029)

10.2 North America Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis

10.3 EMEA Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis

10.4 China Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis

10.5 Asia-Pacific Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis

10.6 Latin America Deoxyribonucleic Acid (DNA) Vaccines Forecast Market Analysis

11 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Deoxyribonucleic Acid (DNA) Vaccines Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the Deoxyribonucleic Acid (DNA) Vaccines Market?
New players are entering the Deoxyribonucleic Acid (DNA) Vaccines Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What is the estimated value of the Deoxyribonucleic Acid (DNA) Vaccines Market?
The Deoxyribonucleic Acid (DNA) Vaccines Market is expected to reach a reasonable valuation by 2030; now the market is expected to shift its focus from growth to value.
What challenges does the Deoxyribonucleic Acid (DNA) Vaccines Market face in the future?
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Deoxyribonucleic Acid (DNA) Vaccines Market across the extensive corporate landscape.
How is the Deoxyribonucleic Acid (DNA) Vaccines Market's changing dynamics captured?
The Deoxyribonucleic Acid (DNA) Vaccines analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.